What’s Next in Immuno-Oncology - A Visionary Conversation with Dr Ira Mellman
This podcast features a fireside chat between Dr Ira Mellman, PICI and Dr Axel Hoos, Former CEO, Scorpion Therapeutics from the 2026 Immuno-Oncology 360° conference. Drawing on Dr Mellman’s extensive experience and current work at the Parker Institute for Cancer Immunotherapy, this conversation provides:Insight into the scientific and clinical trajectory of immuno-oncologyPerspectives on the evolving role of collaboration and innovative partnership models like PICIDiscussion of the key opportunities and challenges shaping IO innovation at scaleA visionary outlook on what the next chapter of immuno-oncology could look likeTo learn more about the IO360° Summit, please visit https://www.io360summit.com/
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from PharmaTalkRadio
New Biotech-Academia Partnership Approaches to Empower the Drug Development Ecosystem
Developing a Global Clinical Trial Strategy for Emerging Biotechs
How Pharma Teams Evaluate Biotech Companies for Partnerships and Acquisitions
What to Expect at Partnerships with Sites 2026
Get summaries like this every morning.
Free AI-powered recaps of PharmaTalkRadio and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.